Cytokinetics Inc (CYTK)
48.24
+0.58
(+1.21%)
USD |
NASDAQ |
Nov 22, 11:01
Cytokinetics Total Liabilities (Quarterly): 1.450B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.450B |
| June 30, 2024 | 1.415B |
| March 31, 2024 | 1.204B |
| December 31, 2023 | 1.211B |
| September 30, 2023 | 1.179B |
| June 30, 2023 | 1.113B |
| March 31, 2023 | 1.119B |
| December 31, 2022 | 1.123B |
| September 30, 2022 | 1.092B |
| June 30, 2022 | 660.30M |
| March 31, 2022 | 739.99M |
| December 31, 2021 | 597.46M |
| September 30, 2021 | 578.52M |
| June 30, 2021 | 547.81M |
| March 31, 2021 | 509.22M |
| December 31, 2020 | 420.42M |
| September 30, 2020 | 324.51M |
| June 30, 2020 | 310.58M |
| March 31, 2020 | 302.29M |
| December 31, 2019 | 300.75M |
| September 30, 2019 | 207.26M |
| June 30, 2019 | 203.11M |
| March 31, 2019 | 195.24M |
| December 31, 2018 | 185.24M |
| September 30, 2018 | 178.21M |
| Date | Value |
|---|---|
| June 30, 2018 | 172.07M |
| March 31, 2018 | 180.33M |
| December 31, 2017 | 184.97M |
| September 30, 2017 | 179.28M |
| June 30, 2017 | 165.63M |
| March 31, 2017 | 169.99M |
| December 31, 2016 | 75.78M |
| September 30, 2016 | 74.92M |
| June 30, 2016 | 57.42M |
| March 31, 2016 | 55.31M |
| December 31, 2015 | 46.65M |
| September 30, 2015 | 34.90M |
| June 30, 2015 | 37.84M |
| March 31, 2015 | 38.06M |
| December 31, 2014 | 40.90M |
| September 30, 2014 | 13.56M |
| June 30, 2014 | 17.45M |
| March 31, 2014 | 21.10M |
| December 31, 2013 | 28.75M |
| September 30, 2013 | 48.26M |
| June 30, 2013 | 42.57M |
| March 31, 2013 | 6.26M |
| December 31, 2012 | 7.466M |
| September 30, 2012 | 4.742M |
| June 30, 2012 | 4.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
300.75M
Minimum
Dec 2019
1.450B
Maximum
Sep 2024
809.89M
Average
700.15M
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen Inc | 21.31M |
| Scholar Rock Holding Corp | 99.94M |
| Mirum Pharmaceuticals Inc | 435.87M |
| NeuroBo Pharmaceuticals Inc | 9.193M |
| Edgewise Therapeutics Inc | 22.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.436B |
| Shareholders Equity (Quarterly) | -13.91M |
| Debt to Equity Ratio | -47.16 |
| Current Ratio | 9.276 |
| Net Debt Paydown Yield | -0.15% |